Five GSL licence extensions proposed
Extensions to the availability of five products as
general sale list medicines have been proposed by the Medicines Control
Agency.
In consultation letter MLX 276, issued on 22 October,
the MCA says that it wants to make nicotine 2mg lozenges available as
a GSL medicine, in addition to 1mg lozenges.
It also proposes to extend the GSL indications for
1 per cent preparations of clotrimazole (but not clotrimazole-containing
powders) to include tinea cruris. Pack sizes would be restricted to 50g.
Miconazole nitrate spray powder (up to 2 per cent) is to be made available
for the prevention, as well as the treatment, of athlete's foot.
Two further proposed GSL changes are to increase
the maximum pack size of all aspirin 75mg solid dose forms to 28 and to
make sodium picosulphate 2.5mg liquid-filled capsules available in packs
of 24, bringing them in line with the GSL availability of sodium picosulphate
liquid.
Back to Top
|
